Treatment with kudzu extract does not cause an increase in alcohol's intoxicating effects

Jan 18, 2011

Kudzu, a medicinal plant, has long thought to reduce alcohol dependence, but the precise mechanism remains a mystery. Recent research from the McLean Hospital shows that pre-treatment with kudzu extract had little to no effect on the participant's behavioral, physical or cognitive performance.

There are many ways, both medical and traditional, that are used to treat or dependence. In , root extract has been commonly used to reduce, but not eliminate, alcohol consumption and dependence. Despite its history, the mechanism of action for kudzu extract is still unknown, and that is what the current research explores.

Results of the study will be published in the April 2011 issue of Alcoholism: Clinical & Experimental Research and are currently available at Early View.

David M. Penetar, senior author of the study and assistant Professor of Psychology in the Department of Psychiatry at McLean Hospital, said that kudzu has been around for centuries to treat alcohol intoxication, hangovers and other related problems in humans. But, how kudzu manages this is still not understood. One possibility is through the different isoflavones, which are biologically active molecules that can affect physiology, contained within the kudzu extract.

"Recently, preclinical studies with animals have shown reductions in when treated with isoflavones contained in the kudzu root," said Penetar. "Therefore, the next step in the research was to assess the effects of kudzu extract on different physical, behavioral and cognitive features in humans."

The researchers observed 12 men and women in a double-blind placebo-controlled study. The participants were either treated with kudzu or a placebo for nine days, and then received a medium or high alcohol challenge to determine how prominently they presented alcohol-related symptoms.

The results showed pre-treatment with kudzu extract had little to no effect on the participant's behavioral, physical or . However, the researchers did note that treatment with kudzu caused an increase in heart rate, skin temperature and blood ethanol levels in the participants. Based on this, the researchers hypothesized that an increase in blood ethanol levels could translate into increased effects from the first alcoholic drink and delay an individual's desire for subsequent drinks.

"The fact that participants experienced a rapid rise in blood alcohol levels when pre-treated with kudzu has no apparent explanation and therefore requires additional research," said Penetar. For the researchers, the next step is to determine if kudzu alters regional brain blood flow using an fMRI.

"If alcohol reaches the brain earlier, people might stop drinking earlier or drink less because they achieve the desired intoxication level earlier, with less ," said Robert Swift, a Professor of Psychiatry and Human Behavior at Brown University and the Providence VA Medical Center.

"It is also possible that there is another, as yet undiscovered compound in the mixture that accounts for the effects. Thus, the mechanism of action of the kudzu extract remains unknown."

Explore further: Amgen misses 1Q views as higher costs cut profit

Provided by Alcoholism: Clinical & Experimental Research

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Invasive plant potential threat to Canadian landscape

Jun 20, 2007

It might sound like something out of a 1950s B-movie but the potential proliferation of the native Asian tropical plant kudzu here in Canada is no imaginary threat, warns Professor Rowan Sage of ecology and evolutionary biology. ...

Recommended for you

Amgen misses 1Q views as higher costs cut profit

Apr 22, 2014

Despite higher sales, biotech drugmaker Amgen's first-quarter profit fell 25 percent as production and research costs rose sharply, while the year-ago quarter enjoyed a tax benefit. The company badly missed ...

Valeant, Ackman make $45.6B Allergan bid

Apr 22, 2014

Valeant Pharmaceuticals and activist investor Bill Ackman have unveiled details of their offer to buy Botox maker Allergan, proposing a cash-and-stock deal that could be worth about $45.6 billion.

User comments : 0

More news stories

FDA proposes first regulations for e-cigarettes

The federal government wants to prohibit sales of electronic cigarettes to minors and require approval for new products and health warning labels under regulations being proposed by the Food and Drug Administration.

Rising role seen for health education specialists

(HealthDay)—A health education specialist can help family practices implement quality improvement projects with limited additional financial resources, according to an article published in the March/April ...

When things get glassy, molecules go fractal

Colorful church windows, beads on a necklace and many of our favorite plastics share something in common—they all belong to a state of matter known as glasses. School children learn the difference between ...

FCC to propose pay-for-priority Internet standards

The Federal Communications Commission is set to propose new open Internet rules that would allow content companies to pay for faster delivery over the so-called "last mile" connection to people's homes.

SK Hynix posts Q1 surge in net profit

South Korea's SK Hynix Inc said Thursday its first-quarter net profit surged nearly 350 percent from the previous year on a spike in sales of PC memory chips.